Brief: Harvard Bioscience - Exploring Alternative Capital Sources For Refinancing Outstanding Indebtedness By June 30
12/03/2025 10:17
March 12 (Reuters) - Harvard Bioscience Inc HBIO.O: HARVARD BIOSCIENCE - EXPLORING ALTERNATIVE CAPITAL SOURCES FOR REFINANCING OUTSTANDING INDEBTEDNESS BY JUNE 30 HARVARD BIOSCIENCE INC - COMPANY FACES SUBSTANTIAL DOUBT ABOUT ABILITY TO CONTINUE AS GOING CONCERN HARVARD BIOSCIENCE - EXPECTS AVAILABLE CASH TO FINANCE OPERATIONS WHILE CO WORKS ON CREDIT AGREEMENT REFINANCING Source text: [ID:n0001171843-25-001416] Further company coverage: HBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance